Elemen-Nanosyn, formerly known as Nanosyn, is a market leader in the performance of biochemical, cell-based, and bio-analytical assays
For more than 25 years, our industry-leading scientists have been supporting the pharmaceutical industry and academic research ranging from the initial stages of drug discovery to pre-clinical studies.
Element-Nanosyn offers high-content, functional (activity-based) kinase profiling services developed by our industry-leading scientists. Our services are unique and include:
- • An extensive list of kinases: Our current kinase panel comprises of 330 non-redundant wild-type kinases representing >60% of the human kinome. We also offer an extensive range of assays for mutant kinase variants.
- • A broad range of cell-based kinase assays: Our cell-based kinase assays include a large panel of target engagement NanoBRET assays, phospho-protein assays, protein degradation assays (PROTACs), cytotoxicity assays, cytokine ELISAs, and flow-cytometry assays.
- • A variety of bio-analytical kinase assays: Our bio-analytical kinase assays support the characterization of covalent kinase inhibitors, compound stability/reactivity, prodrug load, biomarker discovery and pre-clinical assessment of the kinase drug efficacy in human and animal samples.
- • Flexible test formats: We offer flexible test formats ranging from high throughput profiling and HTS to dose-response studies and sophisticated mechanism of action studies, including Ki, Kinact/Ki and residence time determinations. Our detection platforms include TR-FRET, ADP-formation, LC/MS/MS and microfluidic electrophoresis mobility shift technology*.
- • Competitive pricing: We perform screening of test compounds against 330 kinase panel at very competitive price on a monthly basis.
- • Regular testing: The dose-response, mechanism of action studies, cell-based, and bio-analytical studies are performed regularly and completed within our standard 1-2 weeks turnaround time**. All assays are performed at our state-of-the-art facility in Santa Clara, California.
Explore all available kinase assays
- • Wild type kinases
- • Mutant kinases
- • Kinase Target engagement NanoBRET assays
- • Mechanism of action assays
- • Cell assays
- • Bio-analytical assays
Rapidly advance your development efforts with our innovative kinase assay services tailored to meet your needs
Please contact us to get a quote and schedule your services.
Publications
We are proud of our collaborations with top academic and pharmaceutical entities. Please explore these kinase research studies co-authored by Nanosyn and/or citing Nanosyn kinase services published in the prestigious scientific journals:
- • Elkins JM et al. Comprehensive characterization of the Published Kinase Inhibitor Set. Nature Biotechnology. 2016 Jan;34(1):95-103.
- • Bradshaw JM et al. Prolonged and tunable residence time using reversible covalent kinase inhibitors. Nature Chemical Biology. 2015 Jul;11(7):525-31.
- • Hall A et al. Discovery and characterization of a novel series of chloropyrimidines as covalent inhibitors of the kinase MSK1. ACS Med Chem Lett. 2022 Jun 25;13(7):1099-1108.
- • de Campos CB et al. Identification of PIKfyve kinase as a target in multiple myeloma. Haematologica. 2020 Jun;105(6):1641-1649.
- • Melissa Hopper et al. Relative selectivity of covalent inhibitors requires assessment of inactivation kinetics and cellular occupancy: A case study of ibrutinib and acalabrutinib. Journal of Pharmacology and Experimental Therapeutics. 2020 Mar; 372 (3) 331-338.
- • John E. Bisi et al. Preclinical characterization of G1T28: A novel CDK4/6 inhibitor for reduction of chemotherapy-induced myelosuppression. Mol Cancer Ther. May 2016; 15(5)
*- The microfluidic electrophoresis technology is used for assay development and kinetic studies only
**- Turnaround time indicated is for standard biochemical and cell assays. Some new assays will require a longer turnaround time.
Click on the orange "Get more information" button and fill out the form. A member of our team will be in touch with you.
Let us know what you're looking for
Your global partner from discovery to market
Still researching? Here are a handful of our many services to help you achieve regulatory approval quickly and efficiently.
![Nanosyn is proud to be part of Element.](/-/media/images/sectors/life-sciences/nanosyn-element-640x480.jpg?h=283&w=378&la=en&hash=86784CA0B0666C07B5B2FBA8B1D34B79)
Drug Discovery and Development
Discover active drug candidates faster and accelerate time to market with Element's integrated CDMO services platform that supports the entire development lifecycle.
![Analytical and micro release testing](/-/media/images/sectors/life-sciences/release-640x480.jpg?h=283&w=378&la=en&hash=127E62F5E1B2E4F3102099F34CB9DE5E)
API Manufacturing
You'll benefit from a single CDMO partner throughout the product lifecycle, starting with the identification of synthetic routes for early-phase API supply, through small-scale commercial API supply.
![Comprehensive drug discovery and development](/-/media/images/sectors/pharmaceuticals/drug-discovery-development-640x480.jpg?h=283&w=378&la=en&hash=504475F354D69BBBD6ADED49B8479A2D)
Discovery Biology
Establish a strong foundation for commercially successful therapies and advance from concept to candidate. Accelerate pre-clinical drug discovery with a large number of biochemical and cell-based assays.
![Connect with Element Life Sciences.](/-/media/images/sectors/pharmaceuticals/life-sciences-event-640x480.jpg?h=283&w=378&la=en&hash=00BD0E094EBB8F3C2EB14333268E7194)
Discovery Chemistry
Explore or support a theory of mechanism of action on a receptor or enzyme with complete medicinal chemistry programs designed and carried out by Element - including design, synthesis and scale-up of proprietary drugs.
![Pharmaceutical CMC Product Development Formulation](/-/media/images/sectors/pharmaceuticals/pharma-cmc-product-development-formulation-480x640.jpg?h=283&w=378&la=en&hash=BAC311A833B8B609B1ED2C0BFCBB3EA0)
Pharmaceutical Pre-Formulation & Formulation Development Services
Element’s pre-formulation and formulation development services help enhance delivery performance and stability of your parenteral, ophthalmic, and topical drug products.
![Clinical trial material manufacturing](/-/media/images/sectors/pharmaceuticals/clinical-trial-mfg-640x480.jpeg?h=283&w=378&la=en&hash=B8546384811E1828782E0EF5C5541571)
Pre-Clinical and GMP Clinical Trial Material Manufacturing
Element offers flexible, complete and seamless clinical-scale manufacturing support throughout the entire drug development life cycle, from pre-clinical manufacturing services to phase I and II clinical trial material manufacturing solutions.
![Connect with Element Life Sciences.](/-/media/images/sectors/pharmaceuticals/life-sciences-event-640x480.jpg?h=283&w=378&la=en&hash=00BD0E094EBB8F3C2EB14333268E7194)
Chemistry, Manufacturing, and Controls (CMC) Consulting Services
We provide consulting services for Chemistry, Manufacturing, and Controls (CMC) product development in the pharmaceutical and biotechnological industries.
![Bioceuticals](/-/media/images/events/extractables-leachables-640.jpeg?h=283&w=378&la=en&hash=33201BF860545EB5C5F5002E953D035A)
Extractables and Leachables Studies
Our extractables and leachables studies offer tailored solutions that ensure patient safety and compliance with industry standards.